Healthier kids, brighter futures

About Us

Roger Reddel BSc (Med) MBBS PhD FRACP, Director

Roger Reddel is Director of Children's Medical Research Institute (CMRI), and the Sir Lorimer Dods Professor, Sydney Medical School, University of Sydney. He also heads CMRI's Cancer Research Unit, and directs CellBank Australia. He obtained his medical degrees from the University of Sydney, trained in medical oncology at Royal Prince Alfred Hospital, and is a Fellow of the Royal Australasian College of Physicians.

Roger completed a PhD in cancer cell biology at the Ludwig Institute for Cancer Research in the University of Sydney's Department of Cancer Medicine, and received an NHMRC CJ Martin Fellowship and a Fulbright Fellowship to undertake postdoctoral research at the National Cancer Institute, Bethesda, Maryland, USA. He returned to Sydney to establish a laboratory at CMRI, attracted by the Institute's culture of fostering high quality basic research, and with the support of Cancer Council NSW's Bicentennial Fellowship. He has continued to receive major support from the Cancer Council, including being awarded the Carcinogenesis Fellowship for ten years, and Program Grants for five years. His team is also supported by Cancer Institute NSW, the Judith Hyam Memorial Trust Fund for Cancer Research, Rotary Club of Sydney, and the National Health and Medical Research Council of Australia.

Professor Reddel was awarded the Ramaciotti Medal for Excellence in Biomedical Research in 2007, was elected as a Fellow of the Australian Academy of Science in 2010, in 2011 received the NSW Premier's Award for Outstanding Cancer Researcher of the Year, and in 2017 was awarded the Neil Hamilton Fairley Medal by The Royal Australasian College of Physicians. Professor Reddel is a director of Cure Cancer Australia Foundation. He serves on editorial boards of a number of international cancer research journals, and on national and international scientific advisory panels.

Professor Reddel has been Director of the Institute since 2007 and serves on the Institute’s Finance and Investment Committee.

Visit the Cancer Research Unit page.